Concepedia

Author

Jorge Salmerón

Mexican Social Security InstituteORCID

Also Known As

C Porras, J SALMERON, J Salmeron, J Salmeron-Castro, J Salmerón, J Salmerón-Castro, J. Salmeron, J. Salmerón, J. Salmerón-Castro, Jack Cuzick

404

Publications

22.2K

Citations

62

H-Index

184

Concepts

All Affiliations

Mexican Social Security InstituteInstituto Nacional de Salud PúblicaUniversidad Nacional Autónoma de MéxicoMoffitt Cancer CenterNational Institute of Genomic Medicine
JS

About

Jorge Salmerón is an author at Mexican Social Security Institute specializing in medicine, public health, and epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

34

65

8.8K

2

Public Health

32

54

6.6K

3

Health Sciences

12

13

418

4

Social Sciences

4

4

624

5

Education

1

1

52

Jorge Salmerón

×

210

Publications

21K

Citations

60

H-Index

YearCitations

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez,

New England Journal of Medicine

2006

1.8K

Dietary Fiber, Glycemic Load, and Risk of Non—insulin-dependent Diabetes Mellitus in Women

Jorge Salmerón

JAMA

1997

1.7K

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Jorma Paavonen, Paulo Naud, Jorge Salmerón,

The Lancet

2009

1.6K

Dietary Fiber, Glycemic Load, and Risk of NIDDM in Men

Jorge Salmerón, Alberto Ascherio, Eric B. Rimm,

Diabetes Care

1997

1.4K

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen, David Jenkins, F. Xavier Bosch,

The Lancet

2007

1.3K

Dietary fat intake and risk of type 2 diabetes in women

Jorge Salmerón, Frank B. Hu, JoAnn E. Manson,

American Journal of Clinical Nutrition

2001

820

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Matti Lehtinen, Jorma Paavonen, Cosette M. Wheeler,

The Lancet Oncology

2011

693

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Cosette M. Wheeler, Xavier Castellsagué, Suzanne M. Garland,

The Lancet Oncology

2011

499

Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study

Anna R. Giuliano, Ji‐Hyun Lee, William J. Fulp,

The Lancet

2011

486

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

Laia Alemany, Maëlle Saunier, Isabel Alvarado‐Cabrero,

International Journal of Cancer

2014

360

Page 1